Predicting Oxygen Desaturation in Chronic Obstructive Pulmonary Disease (COPD) Patients

February 25, 2011 updated by: Villa Pineta Hospital

Composite Analysis on Factors That Predict Oxygen Desaturation During Walking in COPD

Oxygen desaturation (SO2 < 88-90%) during walking is a common clinical feature of Chronic Obstructive Pulmonary Disease (COPD) patients. By a predicted analysis our study is aimed to evaluate anthropometric and functional characteristics of COPD patients correlated with oxygen desaturation during Six-minute walking test (6MWT).

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Italy
    • Modena
      • Pavullo nel Frignano, Modena, Italy, 41026
        • Villa Pineta Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

COPD patients

Description

Inclusion Criteria:

  • COPD patients
  • Ability to perform 6MWT
  • Normal oxygen saturation at rest and at the begin of 6MWT

Exclusion Criteria:

  • No-COPD patients
  • Chronic Respiratory Failure patients in Long-term oxygen therapy (LTOT)
  • Any co-morbidities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Walking desaturation group
COPD patients that at the end of 6MWT have SO2 nadir <88-90%
Walking No-desaturation group
COPD patients that at the end of 6MWT have SO2 nadir >88-90%

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygen saturation nadir (SO2 nadir)
Time Frame: Measured at the end of 6MWT
Measured by change in percentage (%)
Measured at the end of 6MWT

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Villa Pineta Hospital

Investigators

  • Principal Investigator: Ernesto Crisafulli, MD, PhD, Villa Pineta Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2010

Study Completion (ACTUAL)

February 1, 2011

Study Registration Dates

First Submitted

February 24, 2011

First Submitted That Met QC Criteria

February 24, 2011

First Posted (ESTIMATE)

February 25, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

February 28, 2011

Last Update Submitted That Met QC Criteria

February 25, 2011

Last Verified

February 1, 2011

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • VP03-2010

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COPD

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe